Etodolac, a nonsteroidal anti-inflammatory drug (NSAID), was developed to alleviate inflammation and pain associated with various conditions, particularly arthritis. Approved by the FDA in 1991, Etodolac has undergone extensive clinical trials demonstrating its efficacy in managing osteoarthritis, rheumatoid arthritis, and postoperative pain. The molecule works by targeting specific enzymes involved in the inflammatory process, making it a valuable option for individuals requiring long-term pain management.

FDA-approved uses of Etodolac include:

• Osteoarthritis management
• Rheumatoid arthritis treatment
• Relief of acute pain, such as post-surgical pain

Etodolac is administered orally, typically in tablet or capsule form. Dosages vary based on the condition and patient needs:

• Immediate-release tablets: 200 mg to 400 mg, taken 2-3 times daily
• Extended-release tablets: 400 mg to 600 mg, taken once daily

Common side effects:

• Nausea
• Diarrhea or constipation
• Dizziness or headache
• Indigestion or abdominal pain

Serious side effects:

• Severe stomach pain or bloody stools (signs of gastrointestinal bleeding)
• Unexplained weight gain or swelling (potential kidney issues)
• Shortness of breath or chest pain (possible cardiovascular complications)
• Yellowing of the skin or eyes (indicates liver problems)

• Serious cardiovascular risks: Increased risk of heart attack or stroke with prolonged use.
• Gastrointestinal issues: Risk of ulcers, bleeding, or perforation.
• Kidney impairment: Use cautiously in patients with renal dysfunction.
• Hypersensitivity reactions: Contraindicated in individuals allergic to NSAIDs.
• Pregnancy: Avoid during the third trimester due to potential harm to the fetus.

Patients should inform their doctor of any pre-existing medical conditions, particularly heart disease, high blood pressure, kidney or liver disorders, and a history of gastrointestinal bleeding. Avoid combining Etodolac with other NSAIDs or anticoagulants unless directed by a healthcare provider. Regular monitoring of kidney and liver function is advised during prolonged use. Patients should stay hydrated to reduce the risk of renal complications.

Etodolac should always be taken under a healthcare provider's supervision. Avoid consuming alcohol while on the medication, as it increases the risk of gastrointestinal side effects. Take the drug with food or milk to minimise stomach discomfort. Patients should report any unusual symptoms or side effects promptly to their doctor. Periodic check-ups to assess liver and kidney function are recommended during long-term treatment.

1. https://www.drugs.com/etodolac.html
2. https://go.drugbank.com/drugs/DB00749
3. https://pubchem.ncbi.nlm.nih.gov/compound/Etodolac

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider before starting or stopping any medication.